What Do We Do with Methicillin-Resistant Staphylococcus aureus in Surgery?

  • Giorgio Zanetti


Methicillin-resistant Staphylococcus aureus (MRSA) is typical of the burden of antimicrobial resistance in nosocomial infections. S. aureus is one of the most frequent nosocomial pathogens, and the prevalence of methicillin resistance has been constantly rising among S. aureus strains over the last four decades. This has been responsible for an increase in length of hospital stay, treatment-related complications, costs, and, in some instances, attributable mortality.


Methicillin Resistance Infect Control Hosp Intranasal Mupirocin European Antimicrobial Resistance Surveillance System Lococcus Aureus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abboud CS, Wey SB, Baltar VT (2004) Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg 77:676–683.CrossRefPubMedGoogle Scholar
  2. Anonymous (1995) Recommendations for preventing the spread of vancomycin resist ance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 44:1–13.Google Scholar
  3. Anonymous (2002) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 30:458–475.Google Scholar
  4. Anonymous (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485.Google Scholar
  5. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50:59–69.CrossRefPubMedGoogle Scholar
  6. Bischoff WE, Wallis ML, Tucker KB, Reboussin BA, Sherertz RJ (2004) Staphylococcus aureus nasal carriage in a student community: Prevalence, clonal relationships, and risk factors. Infect Control Hosp Epidemiol 25:485–491.CrossRefPubMedGoogle Scholar
  7. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB (2004) Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: A meta-analysis. Clin Infect Dis 38:1357–1363.CrossRefPubMedGoogle Scholar
  8. Borger MA, Rao V, Weisel RD, Ivanov J, Cohen G, Scully HE, David TE (1998) Deep sternal wound infection: Risk factors and outcomes. Ann Thorac Surg 65:1050–1056.CrossRefPubMedGoogle Scholar
  9. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocagoz S, Oztop AY, Vandenbroucke-Grauls CM, Harbarth S, Pittet D (2005) Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 5:653–663.CrossRefPubMedGoogle Scholar
  10. Bratzler DW, Houck PM (2004) Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38:1706–1715.CrossRefPubMedGoogle Scholar
  11. Cespedes C, Said-Salim B, Miller M, Lo SH, Kreiswirth BN, Gordon RJ, Vavagiakis P, Klein RS, Lowy FD (2005) The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 191:444–452.CrossRefPubMedGoogle Scholar
  12. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K (2001) Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71:1572–1578.CrossRefPubMedGoogle Scholar
  13. Clement S, Vaudaux P, Francois P, Schrenzel J, Huggler E, Kampf S, Chaponnier C, Lew D, Lacroix JS (2005) Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 192:1023–1028.CrossRefPubMedGoogle Scholar
  14. Combes A, Trouillet JL, Joly-Guillou ML, Chastre J, Gibert C (2004) The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus. Clin Infect Dis 38:822–829.CrossRefPubMedGoogle Scholar
  15. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 36:53–59.CrossRefPubMedGoogle Scholar
  16. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R (1999) Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 20:31–36.CrossRefPubMedGoogle Scholar
  17. Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, Kaye KS (2004) Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 38:1555–1560.CrossRefPubMedGoogle Scholar
  18. Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, Marsh RJ, Pfaller MA, McGowan JE Jr, Scully BE (1993) Elimination of Staphylococcus aureus nasal carriage in health care workers: Analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 17:466–474.PubMedGoogle Scholar
  19. Dziekan G, Hahn A, Thune K, Schwarzer G, Schafer K, Daschner FD, Grundmann H (2000) Methicillin-resistant Staphylococcus aureus in a teaching hospital:Investigation of nosocomial transmission using a matched case–control study. J Hosp Infect 46:263–270.CrossRefPubMedGoogle Scholar
  20. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592–598.CrossRefPubMedGoogle Scholar
  21. Faria NA, Oliveira DC, Westh H, Monnet DL, Larsen AR, Skov R, de Lencastre LH (2005) Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: A nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol 43:1836–1842.CrossRefPubMedGoogle Scholar
  22. Fernandez C, Gaspar C, Torrellas A, Vindel A, Saez-Nieto JA, Cruzet F, Aguilar L (1995) A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J Antimicrob Chemother 35:399–408.CrossRefPubMedGoogle Scholar
  23. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S (2002) Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 123:326–332.CrossRefPubMedGoogle Scholar
  24. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436–1444.CrossRefPubMedGoogle Scholar
  25. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH (1998) Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 69:412–414.CrossRefPubMedGoogle Scholar
  26. Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49:999–1005.CrossRefPubMedGoogle Scholar
  27. Grossi EA, Culliford AT, Krieger KH, Kloth D, Press R, Baumann FG, Spencer FC (1985) A survey of 77 major infectious complications of median sternotomy: A review of 7,949 consecutive operative procedures. Ann Thorac Surg 40:214–223.PubMedCrossRefGoogle Scholar
  28. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D (2000) Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31:1380–1385.CrossRefPubMedGoogle Scholar
  29. Herwaldt LA (2003) Staphylococcus aureus nasal carriage and surgical-site infections. Surgery 134:S2–S9.CrossRefPubMedGoogle Scholar
  30. Herwaldt LA, Cullen JJ, French P, Hu J, Pfaller MA, Wenzel RP, Perl TM (2004) Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 25:481–484.CrossRefPubMedGoogle Scholar
  31. Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC, Blumberg HM, King MD (2005) Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: Emergence of community-associated MRSA nasal carriage. Clin Infect Dis 41:159–166.CrossRefPubMedGoogle Scholar
  32. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136.CrossRefPubMedGoogle Scholar
  33. Jernigan JA (2004) Is the burden of Staphylococcus aureus among patients with surgical-site infections growing? Infect Control Hosp Epidemiol 25:457–460.CrossRefPubMedGoogle Scholar
  34. Jevons MP, COE AW, Parker MT (1963) Methicillin resistance in staphylococci. Lancet 1:904–907.CrossRefGoogle Scholar
  35. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, van Belkum A, Kluytmans JA (2002) Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35:353–358.CrossRefPubMedGoogle Scholar
  36. Kluytmans JA, Mouton JW, VandenBergh MF, Manders MJ, Maat AP, Wagenvoort JH, Michel MF, Verbrugh HA (1996) Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17:780–785.CrossRefPubMedGoogle Scholar
  37. Kreter B, Woods M (1992) Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 104:590–599.PubMedGoogle Scholar
  38. Laupland KB, Conly JM (2003) Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: An evidence-based review. Clin Infect Dis 37:933–938.CrossRefPubMedGoogle Scholar
  39. Lin CH, Hsu RB, Chang SC, Lin FY, Chu SH (2003) Poststernotomy mediastinitis due to methicillin-resistant Staphylococcus aureus endemic in a hospital. Clin Infect Dis 37:679–684.CrossRefPubMedGoogle Scholar
  40. Maki DG, Bohn MJ, Stolz SM, Kroncke GM, Acher CW, Myerowitz PD (1992) Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Cardiovasc Surg 104:1423–1434.PubMedGoogle Scholar
  41. Manian FA, Meyer PL, Setzer J, Senkel D (2003) Surgical site infections associated with methicillin-resistant Staphylococcus aureus: Do postoperative factors play a role? Clin Infect Dis 36:863–868.CrossRefPubMedGoogle Scholar
  42. Martone WJ (1998) Spread of vancomycin-resistant enterococci: Why did it happen in the United States? Infect Control Hosp Epidemiol 19:539–545.CrossRefPubMedGoogle Scholar
  43. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS (2004) Surgical-site infection due to Staphylococcus aureus among elderly patients: Mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 25:461–467.CrossRefPubMedGoogle Scholar
  44. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D (2001) Poststernotomy mediastinitis due to Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 32:877–883.CrossRefPubMedGoogle Scholar
  45. Melzer M, Eykyn SJ, Gransden WR, Chinn S (2003) Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S.aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37:1453–1460.CrossRefPubMedGoogle Scholar
  46. Monnet DL, MacKenzie FM, Lopez-Lozano JM, Beyaert A, Camacho M, Wilson R, Stuart D, Gould IM (2004) Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000. Emerg Infect Dis 10:1432–1441.PubMedGoogle Scholar
  47. Muller AA, Mauny F, Bertin M, Cornette C, Lopez-Lozano JM, Viel JF, Talon DR, Bertrand X (2003) Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 36:971–978.CrossRefPubMedGoogle Scholar
  48. Munoz P, Menasalvas A, Bernaldo de Quiros JC, Desco M, Vallejo JL, Bouza E (1997) Postsurgical mediastinitis: A case–control study. Clin Infect Dis 25:1060–1064.CrossRefPubMedGoogle Scholar
  49. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386.CrossRefPubMedGoogle Scholar
  50. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA (2002) Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346:1871–1877.CrossRefPubMedGoogle Scholar
  51. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP (1991) Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114:101–106.PubMedGoogle Scholar
  52. Saginur R, Croteau D, Bergeron MG (2000) Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. J Thorac Cardiovasc Surg 120:1120–1130.CrossRefPubMedGoogle Scholar
  53. Salminen US, Viljanen TU, Valtonen VV, Ikonen TE, Sahlman AE, Harjula AL (1999) Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery. J Antimicrob Chemother 44:287–290.CrossRefPubMedGoogle Scholar
  54. Scully BE, Briones F, Gu JW, Neu HC (1992) Mupirocin treatment of nasal staphylococcal colonization. Arch Intern Med 152:353–356.CrossRefPubMedGoogle Scholar
  55. Sharma M, Berriel-Cass D, Baran J Jr (2004) Sternal surgical-site infection following coronary artery bypass graft: Prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 25:468–471.CrossRefPubMedGoogle Scholar
  56. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR (1999) Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340:493–501.CrossRefPubMedGoogle Scholar
  57. Tacconelli E, Venkataraman L, De Girolami PC, DAgata EM (2004) Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: Distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 53:474–479.CrossRefPubMedGoogle Scholar
  58. The European Antimicrobial Resistance Surveillance System (2004) EARSS Annual Report 2004. Accessed at http://www.rivm.nl/earss/result/Monitoring_reports/.
  59. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundman H (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 10:1627–1634.PubMedGoogle Scholar
  60. Troillet N, Carmeli Y, Samore MH, Dakos J, Eichelberger K, DeGirolami PC, Karchmer AW (1998) Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 19:181–185.CrossRefPubMedGoogle Scholar
  61. Vardakas KZ, Soteriades ES, Chrysanthopoulou SA, Papagelopoulos PJ, Falagas ME (2005) Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material. Clin Microbiol Infect 11:775–777.CrossRefPubMedGoogle Scholar
  62. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344:11–16.CrossRefGoogle Scholar
  63. Vuorisalo S, Pokela R, Syrjala H (1998) Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery. Infect Control Hosp Epidemiol 19:234–239.CrossRefPubMedGoogle Scholar
  64. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y (2003) Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9:1415–1422.PubMedGoogle Scholar
  65. Wernitz MH, Swidsinski S, Weist K, Sohr D, Witte W, Franke KP, Roloff D, Ruden H, Veit SK (2005) Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 11:457–465.CrossRefPubMedGoogle Scholar
  66. Wertheim HF, Vos MC, Ott A, van BA, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703–705.CrossRefPubMedGoogle Scholar
  67. Wilson AP, Treasure T, Gruneberg RN, Sturridge MF, Ross DN (1988) Antibiotic prophylaxis in cardiac surgery: A prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. J Antimicrob Chemother 21:213–223.CrossRefPubMedGoogle Scholar
  68. Zanetti G, Goldie SJ, Platt R (2001) Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: Example of coronary artery bypass surgery. Emerg Infect Dis 7:820–827.CrossRefPubMedGoogle Scholar
  69. Zanetti G, Platt R (2004) Antibiotic prophylaxis for cardiac surgery: Does the past predict the future? Clin Infect Dis 38:1364–1366.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Giorgio Zanetti
    • 1
  1. 1.Division of Hospital Preventive Medicine and Service of Infectious DiseasesCentre Hospitalier Universitaire VaudoisLausanneSwitzerland

Personalised recommendations